A new computational model can predict antibody structures more accurately
Using this model, researchers may be able to identify antibody drugs that can target a variety of infectious diseases.
Using this model, researchers may be able to identify antibody drugs that can target a variety of infectious diseases.
With models like AlphaFold3 limited to academic research, the team built an equivalent alternative, to encourage innovation more broadly.
Researchers at MIT, NYU, and UCLA develop an approach to help evaluate whether large language models like GPT-4 are equitable enough to be clinically viable for mental health support.
Five MIT faculty members and two additional alumni are honored with fellowships to advance research on beneficial AI.
In a recent commentary, a team from MIT, Equality AI, and Boston University highlights the gaps in regulation for AI models and non-AI algorithms in health care.
The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.
Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
An interdisciplinary team of researchers thinks health AI could benefit from some of the aviation industry’s long history of hard-won lessons that have created one of the safest activities today.